Histologic muscular history in steroid-treated and untreated patients with Duchenne dystrophy
- 24 November 2015
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 85 (21), 1886-1893
- https://doi.org/10.1212/wnl.0000000000002147
Abstract
Objective: Duchenne muscular dystrophy (DMD) is a lethal disease. The outcome measures used in numerous therapeutic trials include skeletal muscle biopsy. We studied the natural history of DMD from the standpoint of muscle histology with the aim of providing a reproducible tool for use in evaluating and comparing any histologic changes occurring in patients with DMD undergoing treatment and hence be able to determine how therapy modulates the histologic evolution of the disease. Methods: Three independent operators analyzed 56 muscle biopsies from 40 patients not treated with steroids, aged 1 to 10 years and 16 individuals treated with steroids, aged 7 to 10 years. We analyzed morphologic measures, normalized every measure for the average number of fibers observed for each year of age, and calculated intraclass correlation coefficients. Results: The average proportion of connective tissue in patients not treated with steroids was 16.98% from ages 1 to 6 years and 30% from ages 7 to 10 years (p < 0.0001). The average proportion in patients treated with steroids was 24.90%. Muscle fiber area mirrored that of connective tissue in both groups. Conclusions: Having provided a reproducible tool for evaluation and comparison of histologic changes occurring in patients undergoing clinical trials, it was observed that at ages 6 to 7 years, fibrotic tissue rapidly peaks to 29.85%; this is a crucial moment when muscle tissue loses its self-regeneration ability, veering toward fibrotic degeneration. These data should be considered when deciding the most suitable time to begin therapy.Keywords
This publication has 36 references indexed in Scilit:
- THE 6‐minute walk test and other endpoints in Duchenne muscular dystrophy: Longitudinal natural history observations over 48 weeks from a multicenter studyMuscle & Nerve, 2013
- Epigenetic control of skeletal muscle regenerationThe FEBS Journal, 2013
- Fibroadipogenic progenitors mediate the ability of HDAC inhibitors to promote regeneration in dystrophic muscles of young, but not old Mdx miceEMBO Molecular Medicine, 2013
- Novel Approaches to Corticosteroid Treatment in Duchenne Muscular DystrophyPhysical Medicine and Rehabilitation Clinics of North America, 2012
- Use of Skeletal Muscle MRI in Diagnosis and Monitoring Disease Progression in Duchenne Muscular DystrophyPhysical Medicine and Rehabilitation Clinics of North America, 2012
- Sculpting Chromatin Beyond the Double HelixCurrent Topics in Developmental Biology, 2011
- Epigenetic regulation of satellite cell activation during muscle regenerationStem Cell Research & Therapy, 2011
- TNF/p38α/Polycomb Signaling to Pax7 Locus in Satellite Cells Links Inflammation to the Epigenetic Control of Muscle RegenerationCell Stem Cell, 2010
- Long-term blinded placebo-controlled study of SNT-MC17/idebenone in the dystrophin deficient mdx mouse: cardiac protection and improved exercise performanceEuropean Heart Journal, 2008
- Muscle histology and creatine kinase levels in the foetus in Duchenne muscular dystrophyNature, 1977